tiprankstipranks
Trending News
More News >
Advertisement

JSML - ETF AI Analysis

Compare

Top Page

JSML

Janus Henderson Small Cap Growth Alpha ETF (JSML)

Rating:71Outperform
Price Target:
The Janus Henderson Small Cap Growth Alpha ETF (JSML) has an overall rating that reflects a mix of strong performers and some weaker holdings. Catalyst Pharma stands out as a key contributor, driven by its solid financial health, raised revenue guidance, and strategic initiatives that position it well for growth. On the other hand, Workiva's high leverage and negative equity weigh down the fund's rating. A notable risk is the ETF's exposure to smaller companies, which can be more volatile and sensitive to market conditions.
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered solid gains so far this year, indicating strong overall momentum.
Sector Diversification
The fund is spread across ten sectors, reducing the risk of being overly dependent on one industry.
Reasonable Expense Ratio
The ETF's expense ratio is relatively low, making it cost-effective for investors.
Negative Factors
Overwhelming U.S. Exposure
The ETF is almost entirely focused on U.S. companies, limiting geographic diversification.
Weak One-Month Performance
The fund has seen a recent dip in performance, which could signal short-term volatility.
High Concentration in Top Holdings
Several top holdings have significant weights, increasing the risk tied to individual stock performance.

JSML vs. SPDR S&P 500 ETF (SPY)

JSML Summary

The Janus Henderson Small Cap Growth Alpha ETF (JSML) is an investment fund that focuses on small-cap companies in the U.S. with strong growth potential. It includes businesses from various sectors, such as technology, healthcare, and industrials. Some of its top holdings are Sterling Infrastructure and Primoris Services, which are leaders in their industries. Investors might consider JSML for its ability to diversify a portfolio and tap into the growth of smaller companies that could expand significantly over time. However, new investors should be aware that small-cap stocks can be more volatile, meaning their prices can rise and fall quickly.
How much will it cost me?The Janus Henderson Small Cap Growth Alpha ETF (JSML) has an expense ratio of 0.30%, meaning you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average because the fund is actively managed, focusing on selecting high-growth small-cap companies rather than tracking a passive index.
What would affect this ETF?JSML's focus on U.S. small-cap growth companies in sectors like technology, health care, and industrials positions it to benefit from innovation, economic expansion, and increased consumer demand. However, small-cap stocks are more sensitive to economic downturns, interest rate hikes, and regulatory changes, which could negatively impact growth-focused firms. Investors should also consider the higher volatility associated with small-cap investments.

JSML Top 10 Holdings

The Janus Henderson Small Cap Growth Alpha ETF (JSML) leans heavily into health care and technology, with these sectors making up over half of its portfolio. Stocks like Enova International and Argan are rising stars, driving performance with strong financial results and strategic growth moves. On the flip side, Workiva is lagging, weighed down by financial risks and valuation concerns. While the fund’s U.S.-focused small-cap strategy offers exposure to innovative companies, mixed results from holdings like Credo Technology suggest some turbulence. Overall, JSML’s positioning reflects a bold bet on emerging leaders in dynamic industries.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Credo Technology Group Holding Ltd2.15%$5.67M$25.33B76.61%
77
Outperform
Enova International2.02%$5.33M$4.02B63.65%
71
Outperform
InterDigital1.95%$5.13M$8.65B65.20%
76
Outperform
Ryman1.91%$5.02M$5.92B-9.40%
66
Neutral
Atmus Filtration Technologies, Inc.1.82%$4.80M$4.32B37.43%
78
Outperform
Argan1.82%$4.79M$4.71B120.09%
73
Outperform
Cactus1.80%$4.75M$3.97B-16.66%
77
Outperform
Haemonetics1.72%$4.53M$3.84B6.50%
70
Outperform
Catalyst Pharma1.68%$4.43M$2.80B15.62%
83
Outperform
Workiva1.66%$4.36M$4.72B-20.97%
52
Neutral

JSML Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
74.15
Positive
100DMA
73.90
Positive
200DMA
68.87
Positive
Market Momentum
MACD
0.27
Negative
RSI
57.55
Neutral
STOCH
54.62
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JSML, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 74.92, equal to the 50-day MA of 74.15, and equal to the 200-day MA of 68.87, indicating a bullish trend. The MACD of 0.27 indicates Negative momentum. The RSI at 57.55 is Neutral, neither overbought nor oversold. The STOCH value of 54.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JSML.

JSML Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$263.32M0.30%
$635.90M0.79%
$393.30M0.55%
$151.70M0.60%
$126.27M0.70%
$111.91M0.52%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JSML
Janus Henderson Small Cap Growth Alpha ETF
75.99
12.32
19.35%
OSCV
Opus Small Cap Value ETF
SEIS
SEI Select Small Cap ETF
TSCV
Thrivent Small Cap Value ETF
SCDV
Bahl & Gaynor Small Cap Dividend ETF
SIXS
ETC 6 Meridian Small Cap Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement